(Q42707118)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24474498%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in children (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24474498%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24474498%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Colin J. Ross

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24474498%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Rod Rassekh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24474498%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Bruce C Carleton

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24474498%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Kaitlyn Shaw

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24474498%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Ursula Amstutz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24474498%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Claudette Hildebrand

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24474498%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Martin Hosking

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24474498%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Kathleen Neville

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24474498%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

J Steven Leeder

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24474498%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

29 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24474498%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

published in

Pediatric Blood & Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24474498%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24474498%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24474498%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

1055-1062

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24474498%20AND%20SRC:MED&resulttype=core&format=json

Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007.

6 March 2020

cites work

1 reference

Incidence and predictors of severe bleeding during warfarin treatment.

21 January 2018

1 reference

Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

Old and new antithrombotic drugs in neonates and infants

21 January 2018

1 reference

Influence of CYP2C9 polymorphisms, demographic factors and concomitant drug therapy on warfarin metabolism and maintenance dose

21 January 2018

1 reference

CYP4F2 genetic variant alters required warfarin dose

21 January 2018

1 reference

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

21 January 2018

1 reference

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose

21 January 2018

1 reference

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing

21 January 2018

1 reference

Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

21 January 2018

1 reference

In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes

21 January 2018

1 reference

VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children.

21 January 2018

1 reference

Vitamin K antagonists in children with heart disease: height and VKORC1 genotype are the main determinants of the warfarin dose requirement

21 January 2018

1 reference

Oral anticoagulation with warfarin is significantly influenced by steroids and CYP2C9 polymorphisms in children with cancer.

21 January 2018

1 reference

Genetic and clinical determinants influencing warfarin dosing in children with heart disease

21 January 2018

1 reference

Warfarin pharmacogenomics in children

21 January 2018

1 reference

Adverse drug reaction active surveillance: developing a national network in Canada's children's hospitals.

21 January 2018

1 reference

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

21 January 2018

1 reference

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

21 January 2018

1 reference

Mechanism-based concepts of size and maturity in pharmacokinetics

21 January 2018

1 reference

Estimation of the warfarin dose with clinical and pharmacogenetic data

21 January 2018

1 reference

Impact of VKORC1 gene polymorphism on interindividual and interethnic warfarin dosage requirement--a systematic review and meta analysis

21 January 2018

1 reference

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

21 January 2018

1 reference

Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients.

21 January 2018

1 reference

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

21 January 2018

1 reference

Warfarin dose prediction in children using pharmacometric bridging--comparison with published pharmacogenetic dosing algorithms

21 January 2018

1 reference

Genetic determinants of response to warfarin during initial anticoagulation

21 January 2018

1 reference

Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatients

21 January 2018

1 reference

Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy.

21 January 2018

1 reference